Jim Cramer
Danaher’s quarterly results show signs of life, and the struggling stock soars
Danaher shares on Tuesday climbed more than 6% after the health-care company’s first-quarter results exceeded expectations — and, crucially, its guidance was left mostly intact despite an evolving economic picture. Count us among the investors breathing a sigh of relief. Revenue for the three months ended March 31 declined 1% year over year to $5.74 […]
Read More
Slowdown in tourists coming to the U.S. puts Disney’s theme park magic at risk
A slump in air travel to the U.S. is emerging in the wake of President Donald Trump’s tariffs, and it could hit Walt Disney ‘s important theme park business where it hurts. With international guests accounting for about 20% of Disney’s park attendance in Orlando, Florida, and Anaheim, California, according to Barclays, the latest data […]
Read More
What the Discover merger approval means for Capital One and 2 other financials
Capital One secured approvals from banking regulators Friday for its $35 billion acquisition of Discover Financial — a deal that analysts believe could have far-reaching benefits beyond just the Club holding. The news Wells Fargo research analysts said the greenlights from the Federal Reserve and the Office of the Comptroller of the Currency highlight a […]
Read More
These are the 4 biggest things we’re watching in the stock market in the week ahead
The stock market heads into Monday on a streak of volatility it just can’t seem to shake. What had been shaping up as a positive holiday-shortened week turned on a dime Wednesday when Federal Reserve Chairman Jerome Powell signaled concern that President Donald Trump ‘s tariffs could increase inflation and slow economic growth. Speaking at […]
Read More
Eli Lilly shares surge on new obesity pill data. What it means for the stock from here
Eli Lilly is tightening its grip on the lucrative weight-loss market as it moves into a new, more convenient phase that promises to broaden the appeal of its breakthrough drugs. The news Club name Lilly said its daily obesity pill was successful in a late-stage trial for Type 2 diabetes — sending shares soaring more […]
Read More
Abbott Labs shares surge on earnings and a big sign of confidence in the business
Shares of Abbott Laboratories jumped Wednesday after the diversified health-care company delivered strong first-quarter results and left its earnings guidance intact — a big sign of confidence in an uncertain time. Revenue in the three months ended March 31 rose 4% to $10.36 billion, narrowly missing the consensus of $10.4 billion, according to estimates compiled […]
Read More
10 beaten-up stocks that are candidates for a rebound — but all are not created equal
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Markets: Stocks are struggling to hold onto gains Tuesday with the market well off its highest levels of the session. Deeply oversold conditions combined with some […]
Read More
Hard-hit Apple bounces back with the market, and an analyst is divided on our drug stocks
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. Wall Street surged Tuesday on increased hopes of tariff deals, following a wickedly volatile session Monday. The Dow Jones Industrial Average climbed around 1,400 points, or 3.7%. The S […]
Read More
We’re exiting our position in a health-care stock to raise some cash
Shortly after the opening bell, we will be exiting our position in GE Healthcare , selling 550 shares at roughly $65. Following Friday’s trade, Jim Cramer’s Charitable Trust will no longer own a position in GEHC. We’re cutting loose our small position in GE Healthcare and raising some cash following two negative developments over the […]
Read More
Don’t overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers
The drug stock is higher over the past month while the S&P 500 has pulled back sharply. Source
Read More